The amendment to the General Health Law concerning overweight, obesity, and Front Labeling Warnings for prepackaged food and non-alcoholic beverages will become into force, as per its publication in the Official Federal Gazette (FOG) on November 8, 2019.

The referred amendment main purpose is to establish new provisions and guidelines regarding those legends, pictograms and warning symbols that the labeling of prepackaged food and non-alcoholic beverages shall contain in case these products exceed maximum levels of (i) energetic content, (ii) added sugars, (iii) saturated fats, (iv) fats, (v) sodium, and (vi) critical nutrients and ingredients as determined by the Ministry of Health.

Critical nutrients are defined as those that deemed to represent a risk factor for chronic diseases.

The referred amendment to the General Health Law will become into force on November 9, 2019. The Executive Power shall adopt those necessary changes to the regulatory framework (e.g., Regulations, Mexican Official Standards, etc.) by no later than May 6, 2020.

As part of the related regulatory modifications, the draft amendment of Mexican Official Standard NOM-051-SCFI-SSA1-2010, General labeling specifications for prepackaged food products and non-alcoholic beverages-Commercial and sanitary information, was published in the FOG on October 11, 2019. To this end, any interested party is allowed to formally file comments regarding the relevant new labeling requirements for prepackaged food and non-alcoholic beverages. The deadline for submitting comments is December 10, 2019.

The Regulatory team at Hogan Lovells is ready to assist you and clarify any questions you have on this matter.

Print:
EmailTweetLikeLinkedIn
Photo of Ernesto Algaba Ernesto Algaba

Partner, Mexico City

With more than 20 years of experience in the Life Sciences industry under his belt, Ernesto Algaba leads the Life Sciences practice for Hogan Lovells in Mexico.

He focuses on health law and regulatory compliance matters for the pharmaceutical and…

Partner, Mexico City

With more than 20 years of experience in the Life Sciences industry under his belt, Ernesto Algaba leads the Life Sciences practice for Hogan Lovells in Mexico.

He focuses on health law and regulatory compliance matters for the pharmaceutical and medical devices industries. He also has broad experience in the cosmetics, food, alcohol, and tobacco, and consumer products industries. His wealth of knowledge covers matters relating to Mexican Official Standards (NOMs), Consumer Protection Law, overland transport, foreign trade, and contracts.

Ernesto tackles clients’ pressing problems by handling their needs to meet expectations. He advises clients on planning and development of innovative projects and on strategic business decisions with respect to the launching of new products, restructuring of activities and businesses, approval and marketing authorization pathways and standards for regulated and nonregulated products, labeling and advertising issues, product liability, and highly specialized regulatory compliance matters. The Latin American Corporate Counsel Association included Ernesto on its 2015 list of recommended lawyers for administrative law.

Photo of Cecilia Stahlhut Cecilia Stahlhut

Counsel, Mexico City

Cecilia Stahlhut Espinosa represents life sciences and consumer products companies in Mexico, with a focus on health and consumer law matters. She works with clients throughout all stages of complex and innovative projects. Her years of experience as external counsel…

Counsel, Mexico City

Cecilia Stahlhut Espinosa represents life sciences and consumer products companies in Mexico, with a focus on health and consumer law matters. She works with clients throughout all stages of complex and innovative projects. Her years of experience as external counsel to many life sciences companies offer her unique insight into the industry.

She has a wealth of experience in regulatory drug matters (pharmaceutical), medical devices and equipment, research and development, biotechnology, compliance of new product technologies, and general health regulatory compliance. Cecilia has particular experience in the regulation of cosmetics, food, alcohol, tobacco, and consumer products in Mexico.

She has also participated in the planning and adoption of regulatory strategies for various companies, with respect to product advertising and labeling, product liability, marketing of high-tech products, and the launching of new products. She also advises clients on sophisticated regulatory structures and the restructuring of business models and operations, clinical research projects, approval and marketing authorization pathways, standards for regulated products, and challenging labeling and advertising issues.

Cecilia has reviewed promotional materials for an extensive range of products and advised clients on promotional activities and compliance of regulations regarding interactions with health care professionals and related organizations.

Recently, Cecilia was seconded to a major orphan drug company to advise on regulatory framework applicable to orphan drugs as well as the ongoing business activities of the client, including contracts, advertising, marketing, pharmacovigilance, and health-corporate governance.